Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

This study has been completed.
Sponsor:
Collaborators:
Research Foundation Flanders
Agentschap voor Innovatie door Wetenschap en Technologie
Information provided by:
Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier:
NCT00495924
First received: July 2, 2007
Last updated: July 7, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Estimated Primary Completion Date: No date given
No publications provided by Katholieke Universiteit Leuven

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):